• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 83 of 100
Donald Trump Campaigns In New Hampshire Ahead Of Primary
HealthTrump Somehow Plans to Negotiate Drug Prices to Zero
By Laura LorenzettiFebruary 12, 2016
BRITAIN-PHARMACEUTICAL-GSK
HealthGlaxoSmithKline Fined $54.3 Million for Preventing Generic Competition
By Laura LorenzettiFebruary 12, 2016
House Oversight Hearing On Prescription Drug Price Increases
Arts & EntertainmentMartin Shkreli Just Offered Kanye West $10 Million For His New Album
By Ben GeierFebruary 11, 2016
Fortune Global Forum 2015
LeadershipTheranos May Lose Its Biggest Blood-Testing Customer
By ReutersFebruary 11, 2016
Mylan Buys Abbott Laboratories Generic Drug Business For $5.3 Billion
HealthMylan Reaches $7.2 Billion Deal for Meda
By Laura LorenzettiFebruary 10, 2016
Medical Records Archive - IMS Health
HealthThis Little-Known Firm Is Getting Rich Off Your Medical Data
By Adam TannerFebruary 9, 2016
Drugs From European Pharmaceuticals Companies As Stocks Outperformed The Stoxx 600 Index By 1.2 percentage Points
HealthU.S. Is Probing a Possible Half-Billion Dollar Health-Care Fraud
By Michal AddadyFebruary 7, 2016
132093105
MPWDear Biopharma Bros, Stop Treating Women Like ‘Chattel’
By Valentina ZaryaFebruary 5, 2016
Controversial Former Pharmaceutical CEO Martin Shkreli Testifies On Oversight In Drug Market
HealthMartin Shkreli Calls U.S. Lawmakers ‘Imbeciles’
By Laura LorenzettiFebruary 4, 2016
House Oversight Hearing On Prescription Drug Price Increases
HealthHow Martin Shkreli Is ‘Trashing’ the Pharma Industry
By Laura LorenzettiFebruary 4, 2016
Former KaloBios Pharmaceuticals Chief Executive Officer Martin Shkreli Court Appearance
HealthMartin Shkreli Seriously Didn’t Care About Jacking Up Drug Prices
By Laura LorenzettiFebruary 3, 2016
Merck & Co. diabetes treatment Januvia sits is arranged for
FinanceMerck’s Blockbuster Drugs Are Losing Steam
By ReutersFebruary 3, 2016
Views Of A CVS Caremark Corp. Store Ahead Of Earns
RetailCVS Opens First Pharmacies Within Target Stores
By Phil WahbaFebruary 3, 2016
Martin Shkreli, CEO Reviled for Drug Price Gouging, Arrested on Securities Fraud Charges
HealthTop-Selling Prescription Drugs Have Seen Huge Price Hikes
By Claire GrodenFebruary 2, 2016
Symbolic - biotechnology - genetic engineering
TechGuess What This Early Skype Investor Is Betting on Now
By ReutersFebruary 2, 2016
1...
  • 81
  • 82
  • 83
  • 84
  • 85
...100
Most Popular
Economy
The Pentagon said Iran War costs $29 billion, but the real cost is closer to $200 billion—and countingplaceholder alt text
By Jacqueline MunisJune 24, 2026
Success
Now worth $200 million, Sarah Jessica Parker credits being ‘one of eight kids that struggled financially’ for her hunger, ambition, and work ethicplaceholder alt text
By Orianna Rosa RoyleJune 24, 2026
Success
After forcing workers back to the office, Goldman Sachs and JPMorgan Chase are now letting their staff work remotely—but only for the World Cupplaceholder alt text
By Orianna Rosa RoyleJune 23, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.